LENSAR Revenue and Competitors
Estimated Revenue & Valuation
- LENSAR's estimated annual revenue is currently $52.4M per year.
- LENSAR's estimated revenue per employee is $313,750
- LENSAR's total funding is $177.5M.
Employee Data
- LENSAR has 167 Employees.
- LENSAR grew their employee count by 1% last year.
LENSAR's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Sales | Reveal Email/Phone |
3 | VP Clinical Affairs | Reveal Email/Phone |
4 | VP, Marketing | Reveal Email/Phone |
5 | Director Sales | Reveal Email/Phone |
6 | Chief Financial Officer | Reveal Email/Phone |
7 | Senior Director Technical Services | Reveal Email/Phone |
8 | Director Engineering - Research and Development | Reveal Email/Phone |
9 | Director Quality | Reveal Email/Phone |
10 | Director Medical Education | Reveal Email/Phone |
LENSAR Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $26.1M | 104 | 0% | $63.5M | N/A |
#2 | $14.3M | 57 | -8% | N/A | N/A |
#3 | $33.1M | 132 | 6% | N/A | N/A |
#4 | $10.8M | 43 | 5% | N/A | N/A |
#5 | $488.3M | 1216 | 0% | N/A | N/A |
#6 | $14.3M | 57 | 10% | N/A | N/A |
#7 | $5M | 20 | -9% | N/A | N/A |
#8 | $95.6M | 381 | -1% | N/A | N/A |
#9 | $16.8M | 67 | 3% | N/A | N/A |
#10 | $57M | 227 | 13% | N/A | N/A |
What Is LENSAR?
LENSAR® is the leader in next-generation femtosecond laser technology for refractive cataract surgery. The LENSAR Laser System offers cataract surgeons precision and accuracy, while optimizing overall visual outcomes. The proprietary Augmented Reality, LENSAR's reconstructed 3-D imaging, measurement, and guidance system, provides high-resolution ocular images in a single scan. This technology facilitates precise surgical incisions and treatment for ultimate accuracy and reliable outcomes, all in a single procedure room. The LENSAR Laser System is the only femtosecond cataract laser built specifically for refractive cataract surgery. Because it was designed from the ground up, every aspect of the laser has been purposefully designed to meet the needs of cataract surgeons. LENSAR, Inc. is committed to revolutionizing refractive eye surgery. Our success depends on talented and motivated individuals who share our passion for making a difference in patients lives. We are a young and vibrant company located in Orlando, FL. We pride ourselves on having a highly collaborative, innovative environment where initiatives and teamwork are valued and individual efforts are recognized. If youre looking for a career that enables you to pursue both professional and personal goals, we invite you to consider a career at LENSAR, Inc. Click on our website link below for current employment opportunities.
keywords:Healthcare$177.5M
Total Funding
167
Number of Employees
$52.4M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
LENSAR News
LENSAR has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than LENSAR,...
LENSAR, Inc. (NASDAQ:LNSR Get Rating) Stock analysts at SVB Leerink cut their Q1 2022 earnings per share estimates for LENSAR in a...
(Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced femtosecond laser surgical solutions for the...
LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced a total of 12 abstracts highlighting LENSAR’s technology have been accepted for presentation at th ...
ORLANDO, Fla.--(BUSINESS WIRE)--Mar 3, 2021-- LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s fourth quarter and full year 202 ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $52.7M | 167 | 4% | N/A |
#2 | $46.7M | 167 | 5% | N/A |
#3 | $49.9M | 168 | 4% | N/A |
#4 | $49.9M | 168 | 26% | N/A |
#5 | $15M | 168 | 6% | N/A |